Navelbine, Taxol, Herceptin and Neupogen in Stage IV Breast Cancer: A Phase I - II Trial

NCT00041470 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

38

Enrollment

OTHER

Sponsor class

Stopped Sponsor withdrew the study

Conditions

Breast Cancer

Interventions

DRUG: Paclitaxel
DRUG: Vinorelbine
DRUG: Herceptin
DRUG: Filgrastim

Sponsor

University of Washington

Collaborators

[object Object]
[object Object]
[object Object]